血小板诱导子宫内膜异位症中的内皮-间质转化及后续纤维化
研究分析了30例卵巢子宫内膜异位囊肿和深部子宫内膜异位症患者的病灶及30例无子宫内膜异位症女性的对照内膜组织,并在体外用血小板共培养人脐静脉内皮细胞。发现病灶中存在CD31与FSP-1双阳性细胞,卵巢子宫内膜异位囊肿病灶比例显著高于深部病灶且正常内膜为零;血小板通过TGF-β1和PDGFR信号诱导内皮-间质转化及纤维化。
要点
- 卵巢子宫内膜异位囊肿病灶中CD31与FSP-1双阳性细胞占FSP-1+成纤维细胞的74.7%±5.4%,显著高于深部病灶的26.8%±26.0%。
- 病灶纤维化程度与间质标志物FSP-1和α-SMA染色水平呈正相关(r=0.91和r=0.81)。
- 中和TGF-β1和PDGFR信号可消除血小板诱导的人内皮细胞内皮-间质转化。
核心结论
- 子宫内膜异位病灶中存在多种来源的肌成纤维细胞,血小板和/或内皮-间质转化可能是治疗子宫内膜异位症的潜在治疗靶点。
研究设计与样本
- 分析30例卵巢子宫内膜异位囊肿和深部子宫内膜异位症患者的病灶样本及30例无子宫内膜异位症女性的对照内膜组织。
- 使用人脐静脉内皮细胞系进行体外实验,采用免疫荧光染色和免疫组化分析内皮细胞和间质细胞标志物。
- 将人脐静脉内皮细胞与活化血小板或对照培养基共培养,并中和TGF-β1和/或PDGFR信号。
主要发现
- 卵巢子宫内膜异位囊肿病灶中CD31与FSP-1双阳性细胞占FSP-1+成纤维细胞的比例为74.7%±5.4%,显著高于深部子宫内膜异位症病灶的26.8%±26.0%(P=5.7×10-5),正常子宫内膜中该比例为0。
- 病灶纤维化程度与病灶间质标志物FSP-1和α-SMA染色水平呈正相关(r=0.91,P<2.2×10-16;r=0.81,P=5.8×10-15)。
- 与活化血小板共培养的人内皮细胞获得提示内皮-间质转化的形态,同时增殖增加、CD31丢失但间质标志物表达显著增加。
- 形态学及基因和蛋白表达改变伴随功能分化,表现为迁移和侵袭能力、收缩性及胶原产生增加。
- 中和TGF-β1和PDGFR信号可消除血小板诱导的人内皮细胞内皮-间质转化。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Do endometriotic lesions undergo endothelial-mesenchymal transition (EndoMT)? DESIGN: Lesion samples from 30 patients with ovarian endometriomas and deep endometriosis, and control endometrial tissue samples from 30 women without endometriosis, were analysed. In-vitro experimentation using the human umbilical vein endothelial cell (HUVEC) line were conducted. Immunofluorescence staining and immunohistochemistry analysis using antibodies against endothelial cell and mesenchymal cell markers were conducted. The HUVEC cells were co-cultured with activated platelets or control medium with and without neutralization of TGF-β1 PDGFR, or both. Their morphology, proliferation and expression levels of genes and proteins known to be involved in EndoMT were evaluated, along with their migratory and invasive propensity, contractility and collagen production capability. RESULTS: The proportion of CD31 and FSP-1 dual-positive cells in FSP-1+ fibroblasts was 74.7% (±5.4%) in ovarian endometrioma lesions, significantly higher than that in deep endometriosis lesions (26.8% ± 26.0%; P = 5.7 × 10-5), and was zero in normal endometrium. The extent of lesional fibrosis correlated positively with staining levels of the lesional mesenchymal markers FSP-1 and α-SMA (r = 0.91; P < 2.2 × 10-16, r = 0.81; P = 5.8 × 10-15, respectively). Human endothelial cells co-cultured with activated platelets acquire a morphology suggestive of EndoMT, concomitant with increased proliferation, loss of CD31 but marked increase in expression of mesenchymal markers. Morphological and gene and protein expression changes are accompanied by functional differentiation reflected by increased migratory and invasive capacity, contractility and collagen production. Neutralization of TGF-β1 and PDGFR signalling abolished platelet-induced EndoMT in human endothelial cells. CONCLUSIONS: Multiple sources of myofibroblasts exist in endometriotic lesions, and implicates platelets, EndoMT, or both, as potential therapeutic targets for treating endometriosis.
引用
- Yan D, Liu X, Xu H, et al. Platelets induce endothelial-mesenchymal transition and subsequent fibrogenesis in endometriosis. Reprod Biomed Online. 2020. PMID: 32709523. doi:10.1016/j.rbmo.2020.03.020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。